CP-944629

CAS : 668990-94-1

Ref. 3D-TBB99094

Informations sur le produit

• Nom: CP-944629
• Marque: Biosynth
• Description: CP-944629 is an investigational drug that has been shown to have anticancer activity. The mechanism of action is currently unknown, but it has been speculated that this drug may act by inhibiting DNA methylation and/or altering the activity of microRNAs. CP-944629 is currently in Phase I clinical trials for the treatment of multiple myeloma and non-small cell lung carcinoma. It has also been shown to induce apoptosis in a number of cancer cells, including those derived from muscle tissue, leukemia, and breast cancer. CP-944629 has not yet been tested in combination with other treatments; however, it has been repurposed as a potential treatment for spinal muscular atrophy (SMA).

Propriétés chimiques

• Masse moléculaire: 372.34 g/mol
• Formule: C₁₉H₁₅F₃N₄O
• Degré de pureté: Min. 95%